Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01255748 · ClinicalTrials.gov registry record
Registry Study for Radiation Therapy Outcomes
A clinical trial of Neoplasms, sponsored by Proton Collaborative Group.
- Recruiting
- Registry status
- 40,000
- Enrollment target
- 20
- Study locations
NCT01255748: Recruiting study of Neoplasms, sponsored by Proton Collaborative Group.
NCT01255748 is a study of Neoplasms that is actively recruiting participants, run by Proton Collaborative Group. The registered enrollment target is 40,000 participants, above the 1,368-participant average among 158 other Neoplasms trials with a reported enrollment target (2824% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01255748, a study of Neoplasms, is actively recruiting participants, sponsored by Proton Collaborative Group.
- RECRUITING
- Registry status
- 40,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.
Conditions Studied
Interventions
- RADIATION Proton Therapy, Photon Therapy, SRS, Brachytherapy
Study Locations (20)
Florida
- South Florida Proton Therapy Institute - Delray Beach
- Ackerman Cancer Center - Jacksonville
- Dwoskin Proton Therapy Center - Miami
- Miami Cancer Institute - Miami
- Orlando Health Cancer Institute - Orlando
Illinois
- OSF HealthCare Cancer Institute - Peoria
- Northwestern Medicine Chicago Proton Center - Warrenville
Kansas
- University of Kansas Proton Therapy Center - Kansas City
- Kansas City Proton Institute - Overland Park
Missouri
- Washington University in St. Louis - St Louis
- Mercy David C. Pratt Cancer Center - St Louis
Arizona
- Mayo Clinic - Scottsdale
Arkansas
- Proton Center of Arkansas - Little Rock
California
- California Protons Cancer Therapy Center - San Diego
Georgia
- Emory Proton Therapy Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,000 participants |
| Start Date | 2009-06 |
What NCT01255748 shows while recruiting
NCT01255748 is an observational study that tracks outcomes without assigning an intervention. Its 40,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,368-participant average among 158 other Neoplasms trials with a reported enrollment target (2824% higher).
The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Proton Therapy, Photon Therapy, SRS, Brachytherapy is the first listed.
NCT01255748 names 20 study sites across 13 states, led by Florida, Illinois, Kansas.
Frequently Asked Questions
What is clinical trial NCT01255748 about?
NCT01255748 is a clinical study titled "Registry Study for Radiation Therapy Outcomes". The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.
What is the current status of trial NCT01255748?
This trial is currently recruiting. The enrollment target is 40,000 participants. The study started on 2009-06.
What conditions does trial NCT01255748 study?
This clinical trial studies the following conditions: Neoplasms.
What interventions are being tested in trial NCT01255748?
The interventions under investigation include: Proton Therapy, Photon Therapy, SRS, Brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT01255748?
This trial is sponsored by Proton Collaborative Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01255748 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01255748's enrollment target sits among peer trials
40,000 3rd of 158 higher than 156 of 158 other Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Resilience in East Asian Immigrants for Advance Care Planning Discussions
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
- NCT05796505 · 37,122 participants · NA
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia